ftInvstr
SURAKSHA · Healthcare ₹353.2 +2.78% Mkt Cap ₹1842 Cr

SURAKSHA

Healthcare Diagnostics & Research
₹353.2
+2.78% today · 30d +8.01%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for SURAKSHA. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹88 Cr
+20.75% YoY
NET PROFIT
₹13 Cr
+40.0% YoY
OPM
35.53%
+1.98pp YoY
EPS
₹2.5
PE 51.81
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-48.2%, h2=-45.9%, h3=-50.0% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
SURAKSHA51.8118.0
SAILIFE103.8124.25
LALPATHLAB57.3731.74
SYNGENE94.416.59
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
68
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 75
Valuation STRETCHED 20
Growth STEADY 64
Profitability HIGH 85
Technicals STRONG 73
Risk LOW 90
Key Stats
TTM PE
51.81
P/B
7.58
52W HIGH
₹360.0
OFF HIGH
-1.89%
DIV YIELD
0.14%
MKT CAP
₹1842 Cr
◉ Active Signals
MACDBullish4.7301
RSI(14)Bullish65.99
Near 52W HighBullish-1.89
Street Consensus
1 analyst
₹350.0
mean target
Low ₹350.0Now ₹353.2High ₹350.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SURAKSHA and at what entry.

Sign up freeSign in